glp 1 competitive landscape GLP-1 Market Size, Share obesity #biotech #glp1 #biopharma |

Patient preference and lifestyle should guide timing decisions for flexible formulations

Combine the medication with a balanced diet and regular exercise routine

Recommendations for future research Future research studies should prioritise adequately powered, multicentre, double-blind RCTs of NAC in PD with rigorous controls, standardised dosing regimens, clearly defined routes of administration, and stratification by disease stage and baseline oxidative stress markers to identify patient subgroups most likely to benefit

The segments dominance is reinforced by mature patient education systems, easy-to-use pen devices, and broad prescriber familiarity built over years of diabetes-care experience

WhiteWBBakrisGLBergenstalRMCannonCPCushmanWCFleckPet al